Literature DB >> 21839083

Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.

Boris V Dons'koi1, Viktor P Chernyshov, Darina V Osypchuk.   

Abstract

In present study human peripheral blood NK cell activation after co-incubation with K569 cell line was investigated by CD69 expression. NK lytic activity was studied by two different assays: TDA (2,2':6',2″-terpyridine-6,6″-dicarboxylate) release assay (TRA) and flow cytometry assay (FCA) that display two approach to cytotoxicity measurement. We also investigated NK cell degranulation activity by estimation of CD107a (LAMPa) expression. Comparison of specific lysis value measured by both cytotoxicity assays showed high correlation coefficient between two methods (r=0.94447). Specific lysis value correlated significantly with CD69+ NK frequency and NK degranulation activity. We show that lymphocyte incubation with K562 results to increase CD69 expression on NK and NKT but not on T lymphocytes. Only a part of peripheral blood NK cells became CD69 positive after incubation with excess of K562 cells. CD69+ NK cell frequencies did not increase after elevation of K562/NK ratio or incubation period that confirmed existence of subset of NK cells able to response to K562. CD69 elevation on NK significantly correlated with NK cytotoxicity (r=0.726). CD69 increases were similar when whole blood or isolated PBMC was used in assay. We also found different capacity to activation in NK subsets that express CD62L at various densities. The results demonstrated that K562 induced CD69 expression displays NK lymphocyte functional condition that associated with cytotoxic function.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21839083     DOI: 10.1016/j.jim.2011.07.016

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  22 in total

1.  In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.

Authors:  Kieran Seay; Candice Church; Jian Hua Zheng; Kathryn Deneroff; Christina Ochsenbauer; John C Kappes; Bai Liu; Emily K Jeng; Hing C Wong; Harris Goldstein
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  CD69+NK cells contribute to the murine hepatitis virus strain 3-induced murine hepatitis.

Authors:  Lin Ding; Tao Chen; Xiao-Jing Wang; Li Zhou; Ai-Chao Shi; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-08-01

3.  Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study.

Authors:  Monika Holubova; Michaela Miklikova; Martin Leba; Daniel Georgiev; Pavel Jindra; Martin Caprnda; Rachele Ciccocioppo; Peter Kruzliak; Daniel Lysak
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-10       Impact factor: 4.553

4.  UV-inactivated HSV-1 potently activates NK cell killing of leukemic cells.

Authors:  Ismael Samudio; Katayoun Rezvani; Hila Shaim; Elyse Hofs; Mor Ngom; Luke Bu; Guoyu Liu; Jason T C Lee; Suzan Imren; Vivian Lam; Grace F T Poon; Maryam Ghaedi; Fumio Takei; Keith Humphries; William Jia; Gerald Krystal
Journal:  Blood       Date:  2016-03-03       Impact factor: 22.113

5.  Vogt-Koyanagi-Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells.

Authors:  M Bonacini; L Cimino; L De Simone; E Bolletta; F Gozzi; A Soriano; F Muratore; A Zerbini; L Fontana; C Salvarani; S Croci
Journal:  Clin Exp Immunol       Date:  2020-12-27       Impact factor: 5.732

6.  Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro.

Authors:  Gitte S Jensen; Howard A Cash; Sean Farmer; David Keller
Journal:  J Inflamm Res       Date:  2017-08-07

7.  Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-time cell electronic sensing system.

Authors:  Ki-Hyun Park; Hyesun Park; Myungshin Kim; Yonggoo Kim; Kyungja Han; Eun-Jee Oh
Journal:  Biomed Res Int       Date:  2013-10-23       Impact factor: 3.411

8.  Cytotoxic activity and subset populations of peripheral blood natural killer cells in patients with chronic pain.

Authors:  Jae Joon Yoon; Ji A Song; Sue Youn Park; Jeong Il Choi
Journal:  Korean J Pain       Date:  2018-01-02

9.  PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells.

Authors:  Rajeev Kumar; Fang Yu; Yuan-Huan Zhen; Bo Li; Jun Wang; Yuan Yang; Hui-Xin Ge; Ping-Sheng Hu; Jin Xiu
Journal:  Onco Targets Ther       Date:  2017-07-13       Impact factor: 4.147

10.  Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization.

Authors:  Annalisa Bosi; Silvia Zanellato; Barbara Bassani; Adriana Albini; Alessandra Musco; Maria Cattoni; Matteo Desio; Elisa Nardecchia; Davide Giuseppe D'Urso; Andrea Imperatori; Lorenzo Dominioni; Douglas M Noonan; Lorenzo Mortara; Antonino Bruno
Journal:  J Immunol Res       Date:  2018-03-29       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.